Global Imatinib Drugs Sales Market Report 2021

Publisher Name :
Date: 05-May-2021
No. of pages: 126
Inquire Before Buying

The global Imatinib Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Imatinib Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

- Capsules

- Tablets

Segment by Application

- Hospitals

- Drug Stores

- Others

The Imatinib Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Imatinib Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company

- Apotex Inc.

- Novartis

- Sanofi S.A.

- Cipla Inc.

- Mylan Pharms Inc.

- Glenmark Pharmaceuticals Ltd.

- Sun Pharmaceuticals

- Actavis Generics

- Dr. Reddy's Laboratories

- Teva Pharmaceutical Industries Ltd.

Global Imatinib Drugs Sales Market Report 2021

Table of Contents
1 Imatinib Drugs Market Overview
1.1 Imatinib Drugs Product Scope
1.2 Imatinib Drugs Segment by Type
1.2.1 Global Imatinib Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Capsules
1.2.3 Tablets
1.3 Imatinib Drugs Segment by Application
1.3.1 Global Imatinib Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospitals
1.3.3 Drug Stores
1.3.4 Others
1.4 Imatinib Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Imatinib Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Imatinib Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Imatinib Drugs Price Trends (2016-2027)
2 Imatinib Drugs Estimates and Forecasts by Region
2.1 Global Imatinib Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Imatinib Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Imatinib Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Imatinib Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Imatinib Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Imatinib Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Imatinib Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Imatinib Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Imatinib Drugs Estimates and Projections (2016-2027)
2.4.3 China Imatinib Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Imatinib Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Imatinib Drugs Estimates and Projections (2016-2027)
2.4.6 India Imatinib Drugs Estimates and Projections (2016-2027)
3 Global Imatinib Drugs Competition Landscape by Players
3.1 Global Top Imatinib Drugs Players by Sales (2016-2021)
3.2 Global Top Imatinib Drugs Players by Revenue (2016-2021)
3.3 Global Imatinib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Imatinib Drugs as of 2020)
3.4 Global Imatinib Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Imatinib Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Imatinib Drugs Market Size by Type
4.1 Global Imatinib Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Imatinib Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Imatinib Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Imatinib Drugs Price by Type (2016-2021)
4.2 Global Imatinib Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Imatinib Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Imatinib Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Imatinib Drugs Price Forecast by Type (2022-2027)
5 Global Imatinib Drugs Market Size by Application
5.1 Global Imatinib Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Imatinib Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Imatinib Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Imatinib Drugs Price by Application (2016-2021)
5.2 Global Imatinib Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Imatinib Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Imatinib Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Imatinib Drugs Price Forecast by Application (2022-2027)
6 North America Imatinib Drugs Market Facts & Figures
6.1 North America Imatinib Drugs Sales by Company
6.1.1 North America Imatinib Drugs Sales by Company (2016-2021)
6.1.2 North America Imatinib Drugs Revenue by Company (2016-2021)
6.2 North America Imatinib Drugs Sales Breakdown by Type
6.2.1 North America Imatinib Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Imatinib Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Imatinib Drugs Sales Breakdown by Application
6.3.1 North America Imatinib Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Imatinib Drugs Sales Breakdown by Application (2022-2027)
7 Europe Imatinib Drugs Market Facts & Figures
7.1 Europe Imatinib Drugs Sales by Company
7.1.1 Europe Imatinib Drugs Sales by Company (2016-2021)
7.1.2 Europe Imatinib Drugs Revenue by Company (2016-2021)
7.2 Europe Imatinib Drugs Sales Breakdown by Type
7.2.1 Europe Imatinib Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Imatinib Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Imatinib Drugs Sales Breakdown by Application
7.3.1 Europe 126 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 126 Sales Breakdown by Application (2022-2027)
8 China Imatinib Drugs Market Facts & Figures
8.1 China Imatinib Drugs Sales by Company
8.1.1 China Imatinib Drugs Sales by Company (2016-2021)
8.1.2 China Imatinib Drugs Revenue by Company (2016-2021)
8.2 China Imatinib Drugs Sales Breakdown by Type
8.2.1 China Imatinib Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Imatinib Drugs Sales Breakdown by Type (2022-2027)
8.3 China Imatinib Drugs Sales Breakdown by Application
8.3.1 China 151 Sales Breakdown by Application (2016-2021)
8.3.2 China 151 Sales Breakdown by Application (2022-2027)
9 Japan Imatinib Drugs Market Facts & Figures
9.1 Japan Imatinib Drugs Sales by Company
9.1.1 Japan Imatinib Drugs Sales by Company (2016-2021)
9.1.2 Japan Imatinib Drugs Revenue by Company (2016-2021)
9.2 Japan Imatinib Drugs Sales Breakdown by Type
9.2.1 Japan Imatinib Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Imatinib Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Imatinib Drugs Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Imatinib Drugs Market Facts & Figures
10.1 Southeast Asia Imatinib Drugs Sales by Company
10.1.1 Southeast Asia Imatinib Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Imatinib Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Imatinib Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Imatinib Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Imatinib Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Imatinib Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Imatinib Drugs Market Facts & Figures
11.1 India Imatinib Drugs Sales by Company
11.1.1 India Imatinib Drugs Sales by Company (2016-2021)
11.1.2 India Imatinib Drugs Revenue by Company (2016-2021)
11.2 India Imatinib Drugs Sales Breakdown by Type
11.2.1 India Imatinib Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Imatinib Drugs Sales Breakdown by Type (2022-2027)
11.3 India Imatinib Drugs Sales Breakdown by Application
11.3.1 India Imatinib Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Imatinib Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Imatinib Drugs Business
12.1 Apotex Inc.
12.1.1 Apotex Inc. Corporation Information
12.1.2 Apotex Inc. Business Overview
12.1.3 Apotex Inc. Imatinib Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Apotex Inc. Imatinib Drugs Products Offered
12.1.5 Apotex Inc. Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Business Overview
12.2.3 Novartis Imatinib Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novartis Imatinib Drugs Products Offered
12.2.5 Novartis Recent Development
12.3 Sanofi S.A.
12.3.1 Sanofi S.A. Corporation Information
12.3.2 Sanofi S.A. Business Overview
12.3.3 Sanofi S.A. Imatinib Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi S.A. Imatinib Drugs Products Offered
12.3.5 Sanofi S.A. Recent Development
12.4 Cipla Inc.
12.4.1 Cipla Inc. Corporation Information
12.4.2 Cipla Inc. Business Overview
12.4.3 Cipla Inc. Imatinib Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Cipla Inc. Imatinib Drugs Products Offered
12.4.5 Cipla Inc. Recent Development
12.5 Mylan Pharms Inc.
12.5.1 Mylan Pharms Inc. Corporation Information
12.5.2 Mylan Pharms Inc. Business Overview
12.5.3 Mylan Pharms Inc. Imatinib Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Mylan Pharms Inc. Imatinib Drugs Products Offered
12.5.5 Mylan Pharms Inc. Recent Development
12.6 Glenmark Pharmaceuticals Ltd.
12.6.1 Glenmark Pharmaceuticals Ltd. Corporation Information
12.6.2 Glenmark Pharmaceuticals Ltd. Business Overview
12.6.3 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Products Offered
12.6.5 Glenmark Pharmaceuticals Ltd. Recent Development
12.7 Sun Pharmaceuticals
12.7.1 Sun Pharmaceuticals Corporation Information
12.7.2 Sun Pharmaceuticals Business Overview
12.7.3 Sun Pharmaceuticals Imatinib Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Sun Pharmaceuticals Imatinib Drugs Products Offered
12.7.5 Sun Pharmaceuticals Recent Development
12.8 Actavis Generics
12.8.1 Actavis Generics Corporation Information
12.8.2 Actavis Generics Business Overview
12.8.3 Actavis Generics Imatinib Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Actavis Generics Imatinib Drugs Products Offered
12.8.5 Actavis Generics Recent Development
12.9 Dr. Reddy's Laboratories
12.9.1 Dr. Reddy's Laboratories Corporation Information
12.9.2 Dr. Reddy's Laboratories Business Overview
12.9.3 Dr. Reddy's Laboratories Imatinib Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Dr. Reddy's Laboratories Imatinib Drugs Products Offered
12.9.5 Dr. Reddy's Laboratories Recent Development
12.10 Teva Pharmaceutical Industries Ltd.
12.10.1 Teva Pharmaceutical Industries Ltd. Corporation Information
12.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
12.10.3 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Products Offered
12.10.5 Teva Pharmaceutical Industries Ltd. Recent Development
13 Imatinib Drugs Manufacturing Cost Analysis
13.1 Imatinib Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Imatinib Drugs
13.4 Imatinib Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Imatinib Drugs Distributors List
14.3 Imatinib Drugs Customers
15 Market Dynamics
15.1 Imatinib Drugs Market Trends
15.2 Imatinib Drugs Drivers
15.3 Imatinib Drugs Market Challenges
15.4 Imatinib Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Imatinib Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Imatinib Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Imatinib Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Imatinib Drugs Sales (K MT) by Region (2016-2021)
Table 5. Global Imatinib Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Imatinib Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Imatinib Drugs Revenue Share by Region (2016-2021)
Table 8. Global Imatinib Drugs Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Imatinib Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Imatinib Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Imatinib Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Imatinib Drugs Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Imatinib Drugs Sales Share by Company (2016-2021)
Table 14. Global Imatinib Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Imatinib Drugs Revenue Share by Company (2016-2021)
Table 16. Global Imatinib Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Imatinib Drugs as of 2020)
Table 17. Global Imatinib Drugs Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Imatinib Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Imatinib Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Imatinib Drugs Sales (K MT) by Type (2016-2021)
Table 22. Global Imatinib Drugs Sales Share by Type (2016-2021)
Table 23. Global Imatinib Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Imatinib Drugs Price (USD/MT) by Type (2016-2021)
Table 25. Global Imatinib Drugs Sales Share by Type (2022-2027)
Table 26. Global Imatinib Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Imatinib Drugs Revenue Share by Type (2022-2027)
Table 28. Global Imatinib Drugs Price (USD/MT) by Type (2022-2027)
Table 29. Global Imatinib Drugs Sales (K MT) by Application (2016-2021)
Table 30. Global Imatinib Drugs Sales Share by Application (2016-2021)
Table 31. Global Imatinib Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Imatinib Drugs Price (USD/MT) by Application (2016-2021)
Table 33. Global Imatinib Drugs Sales (K MT) by Application (2022-2027)
Table 34. Global Imatinib Drugs Sales Share by Application (2022-2027)
Table 35. Global Imatinib Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Imatinib Drugs Revenue Share by Application (2022-2027)
Table 37. Global Imatinib Drugs Price (USD/MT) by Application (2022-2027)
Table 38. North America Imatinib Drugs Sales (K MT) by Company (2016-2021)
Table 39. North America Imatinib Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Imatinib Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Imatinib Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Imatinib Drugs Sales by Type (2016-2021) & (K MT)
Table 43. North America Imatinib Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Imatinib Drugs Sales by Type (2022-2027) & (K MT)
Table 45. North America Imatinib Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Imatinib Drugs Sales by Application (2016-2021) & (K MT)
Table 47. North America Imatinib Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Imatinib Drugs Sales by Application (2022-2027) & (K MT)
Table 49. North America Imatinib Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Imatinib Drugs Sales (K MT) by Company (2016-2021)
Table 51. Europe Imatinib Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Imatinib Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Imatinib Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Imatinib Drugs Sales by Type (2016-2021) & (K MT)
Table 55. Europe Imatinib Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Imatinib Drugs Sales by Type (2022-2027) & (K MT)
Table 57. Europe Imatinib Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Imatinib Drugs Sales by Application (2016-2021) & (K MT)
Table 59. Europe Imatinib Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Imatinib Drugs Sales by Application (2022-2027) & (K MT)
Table 61. Europe Imatinib Drugs Sales Market Share by Application (2022-2027)
Table 62. China Imatinib Drugs Sales (K MT) by Company (2016-2021)
Table 63. China Imatinib Drugs Sales Market Share by Company (2016-2021)
Table 64. China Imatinib Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Imatinib Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Imatinib Drugs Sales by Type (2016-2021) & (K MT)
Table 67. China Imatinib Drugs Sales Market Share by Type (2016-2021)
Table 68. China Imatinib Drugs Sales by Type (2022-2027) & (K MT)
Table 69. China Imatinib Drugs Sales Market Share by Type (2022-2027)
Table 70. China Imatinib Drugs Sales by Application (2016-2021) & (K MT)
Table 71. China Imatinib Drugs Sales Market Share by Application (2016-2021)
Table 72. China Imatinib Drugs Sales by Application (2022-2027) & (K MT)
Table 73. China Imatinib Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Imatinib Drugs Sales (K MT) by Company (2016-2021)
Table 75. Japan Imatinib Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Imatinib Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Imatinib Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Imatinib Drugs Sales by Type (2016-2021) & (K MT)
Table 79. Japan Imatinib Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Imatinib Drugs Sales by Type (2022-2027) & (K MT)
Table 81. Japan Imatinib Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Imatinib Drugs Sales by Application (2016-2021) & (K MT)
Table 83. Japan Imatinib Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Imatinib Drugs Sales by Application (2022-2027) & (K MT)
Table 85. Japan Imatinib Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Imatinib Drugs Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Imatinib Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Imatinib Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Imatinib Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Imatinib Drugs Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Imatinib Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Imatinib Drugs Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Imatinib Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Imatinib Drugs Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Imatinib Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Imatinib Drugs Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Imatinib Drugs Sales Market Share by Application (2022-2027)
Table 98. India Imatinib Drugs Sales (K MT) by Company (2016-2021)
Table 99. India Imatinib Drugs Sales Market Share by Company (2016-2021)
Table 100. India Imatinib Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Imatinib Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Imatinib Drugs Sales by Type (2016-2021) & (K MT)
Table 103. India Imatinib Drugs Sales Market Share by Type (2016-2021)
Table 104. India Imatinib Drugs Sales by Type (2022-2027) & (K MT)
Table 105. India Imatinib Drugs Sales Market Share by Type (2022-2027)
Table 106. India Imatinib Drugs Sales by Application (2016-2021) & (K MT)
Table 107. India Imatinib Drugs Sales Market Share by Application (2016-2021)
Table 108. India Imatinib Drugs Sales by Application (2022-2027) & (K MT)
Table 109. India Imatinib Drugs Sales Market Share by Application (2022-2027)
Table 110. Apotex Inc. Corporation Information
Table 111. Apotex Inc. Description and Business Overview
Table 112. Apotex Inc. Imatinib Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Apotex Inc. Imatinib Drugs Product
Table 114. Apotex Inc. Recent Development
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Imatinib Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Novartis Imatinib Drugs Product
Table 119. Novartis Recent Development
Table 120. Sanofi S.A. Corporation Information
Table 121. Sanofi S.A. Description and Business Overview
Table 122. Sanofi S.A. Imatinib Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Sanofi S.A. Imatinib Drugs Product
Table 124. Sanofi S.A. Recent Development
Table 125. Cipla Inc. Corporation Information
Table 126. Cipla Inc. Description and Business Overview
Table 127. Cipla Inc. Imatinib Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Cipla Inc. Imatinib Drugs Product
Table 129. Cipla Inc. Recent Development
Table 130. Mylan Pharms Inc. Corporation Information
Table 131. Mylan Pharms Inc. Description and Business Overview
Table 132. Mylan Pharms Inc. Imatinib Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Mylan Pharms Inc. Imatinib Drugs Product
Table 134. Mylan Pharms Inc. Recent Development
Table 135. Glenmark Pharmaceuticals Ltd. Corporation Information
Table 136. Glenmark Pharmaceuticals Ltd. Description and Business Overview
Table 137. Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Glenmark Pharmaceuticals Ltd. Imatinib Drugs Product
Table 139. Glenmark Pharmaceuticals Ltd. Recent Development
Table 140. Sun Pharmaceuticals Corporation Information
Table 141. Sun Pharmaceuticals Description and Business Overview
Table 142. Sun Pharmaceuticals Imatinib Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. Sun Pharmaceuticals Imatinib Drugs Product
Table 144. Sun Pharmaceuticals Recent Development
Table 145. Actavis Generics Corporation Information
Table 146. Actavis Generics Imatinib Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Actavis Generics Description and Business Overview
Table 148. Actavis Generics Imatinib Drugs Product
Table 149. Actavis Generics Recent Development
Table 150. Dr. Reddy's Laboratories Corporation Information
Table 151. Dr. Reddy's Laboratories Imatinib Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Dr. Reddy's Laboratories Description and Business Overview
Table 153. Dr. Reddy's Laboratories Imatinib Drugs Product
Table 154. Dr. Reddy's Laboratories Recent Development
Table 155. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 156. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 157. Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Teva Pharmaceutical Industries Ltd. Imatinib Drugs Product
Table 159. Teva Pharmaceutical Industries Ltd. Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Imatinib Drugs Distributors List
Table 163. Imatinib Drugs Customers List
Table 164. Imatinib Drugs Market Trends
Table 165. Imatinib Drugs Market Drivers
Table 166. Imatinib Drugs Market Challenges
Table 167. Imatinib Drugs Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Imatinib Drugs Product Picture
Figure 2. Global Imatinib Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Capsules Product Picture
Figure 4. Tablets Product Picture
Figure 5. Global Imatinib Drugs Sales Market Share by Application in 2021 & 2027
Figure 6. Hospitals Examples
Figure 7. Drug Stores Examples
Figure 8. Others Examples
Figure 9. Global Imatinib Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Imatinib Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Imatinib Drugs Sales (K MT) Growth Rate (2016-2027)
Figure 12. Global Imatinib Drugs Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 13. Global Imatinib Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Imatinib Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Imatinib Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Imatinib Drugs Sales (K MT) Growth Rate (2016-2027)
Figure 17. Europe Imatinib Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Imatinib Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Imatinib Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Imatinib Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Imatinib Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Imatinib Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Imatinib Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Imatinib Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Imatinib Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Imatinib Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Imatinib Drugs Players Market Share by Revenue in Imatinib Drugs: 2016 & 2020
Figure 28. Imatinib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Imatinib Drugs Revenue Share by Type (2016-2021)
Figure 30. Global Imatinib Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Imatinib Drugs Revenue Share by Application (2016-2021)
Figure 32. Global Imatinib Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Imatinib Drugs Sales Market Share by Type in 2020
Figure 34. North America Imatinib Drugs Sales Market Share by Application in 2020
Figure 35. Europe Imatinib Drugs Sales Market Share by Type in 2020
Figure 36. Europe Imatinib Drugs Sales Market Share by Application in 2020
Figure 37. China Imatinib Drugs Sales Market Share by Type in 2020
Figure 38. China Imatinib Drugs Sales Market Share by Application in 2020
Figure 39. Japan Imatinib Drugs Sales Market Share by Type in 2020
Figure 40. Japan Imatinib Drugs Sales Market Share by Application in 2020
Figure 41. Southeast Asia Imatinib Drugs Sales Market Share by Type in 2020
Figure 42. Southeast Asia Imatinib Drugs Sales Market Share by Application in 2020
Figure 43. India Imatinib Drugs Sales Market Share by Type in 2020
Figure 44. India Imatinib Drugs Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Imatinib Drugs
Figure 47. Manufacturing Process Analysis of Imatinib Drugs
Figure 48. Imatinib Drugs Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
  • Global and Japan Dry Eye Products Market Insights, Forecast to 2027
    Published: 30-Jul-2021        Price: US 3900 Onwards        Pages: 168
    Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment. Market Analysis and Insights: Global and Japan Dry Eye Products Market This report focuses on global and J......
  • Global and China Etoposide Market Insights, Forecast to 2027
    Published: 30-Jul-2021        Price: US 3900 Onwards        Pages: 138
    Etoposide is a widely used topoisomerase inhibitor chemotherapy drug. It is a synthetic derivative of podophyllotoxin. Market Analysis and Insights: Global and China Etoposide Market This report focuses on global and China Etoposide market. In 2020, the global Etoposide market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Etoposide market size is expected to grow from US$ XX mi......
  • Global and China Raubasine Market Insights, Forecast to 2027
    Published: 30-Jul-2021        Price: US 3900 Onwards        Pages: 123
    Raubasine is an antihypertensive drug used in the treatment of high blood pressure. Market Analysis and Insights: Global and China Raubasine Market This report focuses on global and China Raubasine market. In 2020, the global Raubasine market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Raubasine market size is expected to grow from US$ XX million in 2020 to US$ XX million by ......
  • Global and Japan Dihydroergotamine Mesylate Market Insights, Forecast to 2027
    Published: 30-Jul-2021        Price: US 3900 Onwards        Pages: 134
    Dihydroergotamine mesylate sustained-release capsules, severe orthostatic hypotension, acute migraine attacks, persistent headaches and vascular headaches. Market Analysis and Insights: Global and Japan Dihydroergotamine Mesylate Market This report focuses on global and Japan Dihydroergotamine Mesylate market. In 2020, the global Dihydroergotamine Mesylate market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX%......
  • Global and Japan Homatropine Hydrobromide Market Insights, Forecast to 2027
    Published: 30-Jul-2021        Price: US 3900 Onwards        Pages: 121
    Homatropine Hydrobromide is used before eye examinations, before and after certain eye surgeries, and to treat certain eye conditions. Market Analysis and Insights: Global and Japan Homatropine Hydrobromide Market This report focuses on global and Japan Homatropine Hydrobromide market. In 2020, the global Homatropine Hydrobromide market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In Japan......
  • Global and China Homatropine Methylbromide Market Insights, Forecast to 2027
    Published: 30-Jul-2021        Price: US 3900 Onwards        Pages: 139
    Homatropine methylbromide is a quaternary ammonium salt of methylhomatropine. Homatropine is used to treat duodenal or stomach ulcers or intestine problems. Market Analysis and Insights: Global and China Homatropine Methylbromide Market This report focuses on global and China Homatropine Methylbromide market. In 2020, the global Homatropine Methylbromide market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% d......
  • Global and United States Metildigoxin Market Insights, Forecast to 2027
    Published: 30-Jul-2021        Price: US 3900 Onwards        Pages: 125
    Methyldigoxigenin is a derivative in which the hydroxyl group at the ?-position of the digoxin terminal is substituted with a methoxy group. Its positive force is similar to digoxin, but it is strong, and the negative gastrointestinal tract has good absorption and fast onset. Market Analysis and Insights: Global and United States Metildigoxin Market This report focuses on global and United States Metildigoxin market. In 2020, the global Metildigoxin market size was U......
  • Global and China Vegetarian Based Capsules Market Insights, Forecast to 2027
    Published: 30-Jul-2021        Price: US 3900 Onwards        Pages: 139
    Vegetarian capsule is made up of cellulose, an important structural component in plants. Market Analysis and Insights: Global and China Vegetarian Based Capsules Market This report focuses on global and China Vegetarian Based Capsules market. In 2020, the global Vegetarian Based Capsules market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Vegetarian Based Capsules market size ......
  • Global and China Gelatin Based Capsules Market Insights, Forecast to 2027
    Published: 30-Jul-2021        Price: US 3900 Onwards        Pages: 158
    Gelatin based capsules are created through a process where hooves, bones, and connective tissues are boiled down into a gel-like substance, put through a cooling process, and then formed into a capsule. Market Analysis and Insights: Global and China Gelatin Based Capsules Market This report focuses on global and China Gelatin Based Capsules market. In 2020, the global Gelatin Based Capsules market size was US$ XX million and it is expected to reach US$ XX million by ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs